Pinnacle Financial Group, Inc.’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
Other funds holding INO
Pinnacle Financial Group, Inc.'s INO Position: Q3 2026 in Review
Pinnacle Financial Group, Inc. opened a new position in Inovio Pharmaceuticals (INO) in Q3 2026: 39 shares worth $48. The stake represents ﹤0.01% of the portfolio and ranks #2238 among its holdings.
111 funds tracked by Wall St. Rank hold INO as of Q3 2026.
- Pinnacle Financial Group, Inc. held 39 shares of Inovio Pharmaceuticals worth $48 as of Q3 2026.
- Inovio Pharmaceuticals was a new Pinnacle Financial Group, Inc. position in Q3 2026.
- Inovio Pharmaceuticals made up ﹤0.01% of Pinnacle Financial Group, Inc.'s portfolio in Q3 2026, its #2238 holding.
- 111 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q3 2026.
Based on Pinnacle Financial Group, Inc.'s 13F filing for Q3 2026, filed 16 Nov 2026.